Bronchial Thermoplasty: Effect on Neuronal and Chemosensitive Component of the Bronchial Mucosa
NCT01839591 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12
Last updated 2025-06-25
Summary
In severe bronchial asthma the mechanism of inflammation and bronchospasm is complex and still not clarified. The smooth muscle cells play an important role from the mechanical point of view, as a culmination of neurogenic stimuli and inflammatory cytokines that determine as final effect the bronchospasm and over time a hypertrophy of the muscular coat. There are some other hypothesis that the smooth muscle cells may play a role as central regulator of chemical mediators that cause bronchospasm and inflammation, although there are currently no firm conclusions 2 According to other studies3,the nerve receptors TRANSIENT RECEPTOR POTENTIAL VANILLOID TYPE 1 have a great importance in the complex mechanism of airway inflammation too. (There are at least 4)
These receptors would intervene according to the following mechanism:
1. Irritants on the bronchial mucosa stimulate the TRANSIENT RECEPTOR POTENTIAL VANILLOID TYPE 1 present on afferent endings of sensory fibers, unmyelinated C (chemiosensitive neurons)
2. On the same afferent axon acting factors with the activation effect (lowering the activation threshold, increase the expression, promote the translocation of TRPV1 receptor on the membrane). Among these factors the neurotrophins of which the most important NERVE GROWTH FACTOR (NGF)
3. The activation of TRPV1 (through release of Ca2 + +) determines two efferent responses:
1. CENTRALLY-MEDIATED
2. LOCAL AXON Reflex
Investigators hypothesized that BT may have a strong influence on the destruction of nerve receptors TRPV1 and unmyelinated nerve fibers located in the mucosa going to stop reflections both central and local authorities responsible for the activation of bronchospasm. In support of this hypothesis, there are some anatomical studies4, which show that these receptors are more numerous at the level of main bronchi which are the main target of BT. Please note in this context that it is already known that in thermoablations commonly used in cardiology it is used a radio frequency with development of heat controlled to 65 °, as in the BT, able to interrupt the circuit nervous responsible for the activation of the circuit causing the abnormal 'arrhythmia.
Conditions
- Severe Persistent Asthma
Interventions
- DEVICE
-
catheter ALAIR
Catheter ALAIR Radiofrequency 65°
Sponsors & Collaborators
-
Azienda USL Reggio Emilia - IRCCS
lead OTHER_GOV
Principal Investigators
-
Nicola NF Facciolongo, M.D.
Study Design
- Allocation
- NA
- Purpose
- BASIC_SCIENCE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-03-11
- Primary Completion
- 2015-04-01
- Completion
- 2016-05-11
- FDA Device
- Yes
Countries
- Italy
Study Locations
More Related Trials
-
Research in Severe Asthma (RISA) Trial
NCT00214539 ·Status: COMPLETED ·Phase: NA
-
Bicentric Prospective Study, Evaluating Bronchial THERMOPLASTY in a Patient Presenting Severe Uncontrolled Asthma
NCT01777360 ·Status: UNKNOWN ·Phase: PHASE3
-
A Prospective Observational Study of Biopredictors of Bronchial Thermoplasty Response in Patients With Severe Refractory Asthma (BTR Study)
NCT01185275 ·Status: COMPLETED
-
RISA Extension Study - Long Term Safety
NCT00401986 ·Status: COMPLETED
-
Effect of Bronchial Thermoplasty on Moderate Bronchial Asthma in China
NCT02965807 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Bronchial Thermoplasty 10+ Year Study
NCT03243292 ·Status: COMPLETED
-
Effectiveness of the Aeroneb in Acute Severe Asthma
NCT03029156 ·Status: COMPLETED ·Phase: NA
-
Bronchial Thermoplasty in Severe Persistent Asthma
NCT01350336 ·Status: COMPLETED ·Phase: NA
-
Bronchial Thermoplasty: Mechanism of Action and Defining Asthma Phenotype
NCT02075151 ·Status: UNKNOWN ·Phase: NA
-
Efficacy of Bronchial Thermoplasty in Korean
NCT02031263 ·Status: UNKNOWN ·Phase: PHASE4
-
Inflammatory Processes in the Airway of Asthmatics With Persistent Bronchial Hyperreactivity
NCT00217854 ·Status: COMPLETED ·Phase: NA
-
Bronchial Thermoplasty for Adults With Severe Asthma in the Biologic Era
NCT07292805 ·Status: RECRUITING ·Phase: NA
-
Spirometric Response to Bronchial Thermoplasty in Patients With Severe Asthma
NCT02241265 ·Status: RECRUITING
-
Asthma Intervention Research (AIR) Trial
NCT00214526 ·Status: COMPLETED ·Phase: NA
-
AIR2 Extension Study to Demonstrate Longer-term (> 1 Year) Durability of Effectiveness
NCT01350414 ·Status: COMPLETED
-
Safety of Bronchial Thermoplasty Performed With the Alair® System During Two Treatment Sessions to Treat Severe Asthma
NCT00803088 ·Status: WITHDRAWN ·Phase: NA
-
The Study About the Identification of Treatable Traits of Severe Asthma and the Construction of Personalized Treatment System
NCT07136025 ·Status: RECRUITING ·Phase: NA
-
AIR Extension Study - Long-Term Safety of Alair Treated Subjects
NCT00448812 ·Status: COMPLETED ·Phase: NA
-
IMT in Asthma: Activity, Coping, Self-Management
NCT07320066 ·Status: RECRUITING
-
Towards Restoring the Physiological Inhibition of Airway Narrowing in Asthma
NCT00279136 ·Status: UNKNOWN
-
Change in Airway Responsiveness After Allergen Exposure
NCT01699594 ·Status: COMPLETED ·Phase: NA
-
How Airway Remodeling and Hyperresponsiveness Contribute to Airflow Obstruction in Asthma
NCT00186693 ·Status: WITHDRAWN
-
NHFT Effects on Symptatheic Drive of Asthma Patients
NCT05704101 ·Status: COMPLETED
-
Stimulation of the Cervical Sympathetic Ganglion for Treatment of Asthma
NCT01724307 ·Status: COMPLETED ·Phase: NA
-
Small Airways Disease (SAD) in Severe Asthma as a Novel Endpoint and Distinct Target for Biological Therapy.
NCT05792592 ·Status: UNKNOWN